======= HOXA7 ======= == Gene Information == * **Official Symbol**: HOXA7 * **Official Name**: homeobox A7 * **Aliases and Previous Symbols**: N/A * **Entrez ID**: [[https://www.ncbi.nlm.nih.gov/gene/?term=3204|3204]] * **UniProt**: [[https://www.uniprot.org/uniprot/P31268|P31268]] * **Interactions**: [[https://thebiogrid.org/search.php?search=HOXA7&organism=9606|BioGRID]] * **PubMed articles**: [[https://www.ncbi.nlm.nih.gov/pubmed/?term=gene%20HOXA7|Open PubMed]] * **OMIM**: [[https://omim.org/entry/142950|Open OMIM]] == Function Summary == * **Entrez Summary**: N/A * **UniProt Summary**: Sequence-specific transcription factor which is part of a developmental regulatory system that provides cells with specific positional identities on the anterior-posterior axis. |Homeobox| |negative regulation of monocyte differentiation| |negative regulation of keratinocyte differentiation| |negative regulation of epidermal cell differentiation| |negative regulation of epidermis development| |regulation of monocyte differentiation| |negative regulation of cell-matrix adhesion| |regulation of keratinocyte differentiation| |negative regulation of epithelial cell differentiation| |negative regulation of leukocyte migration| |negative regulation of myeloid leukocyte differentiation| |regulation of epidermal cell differentiation| |negative regulation of cell-substrate adhesion| |negative regulation of myeloid cell differentiation| |regulation of epidermis development| |embryonic skeletal system morphogenesis| |RNA polymerase II distal enhancer sequence-specific DNA binding| |negative regulation of leukocyte differentiation| |regulation of cell-matrix adhesion| |regulation of myeloid leukocyte differentiation| |embryonic skeletal system development| |negative regulation of hemopoiesis| |regulation of epithelial cell differentiation| |stem cell differentiation| |regulation of leukocyte migration| |regulation of cell-substrate adhesion| |anterior/posterior pattern specification| |regulation of myeloid cell differentiation| |skeletal system morphogenesis| |nuclear membrane| |negative regulation of cell migration| |regulation of leukocyte differentiation| |negative regulation of cell adhesion| |negative regulation of cell motility| |embryonic organ morphogenesis| |negative regulation of cellular component movement| |angiogenesis| |negative regulation of locomotion| |transcription factor binding| |regionalization| |blood vessel morphogenesis| |sequence-specific DNA binding| |embryonic organ development| |pattern specification process| |negative regulation of immune system process| |DNA-binding transcription activator activity, RNA polymerase II-specific| |regulation of hemopoiesis| |blood vessel development| |skeletal system development| |RNA polymerase II proximal promoter sequence-specific DNA binding| |vasculature development| |cardiovascular system development| |embryonic morphogenesis| |chordate embryonic development| |embryo development ending in birth or egg hatching| |tube morphogenesis| |regulation of cell adhesion| |negative regulation of cell differentiation| |tube development| |regulation of cell migration| |negative regulation of transcription by RNA polymerase II| |circulatory system development| |anatomical structure formation involved in morphogenesis| |regulation of cell motility| |negative regulation of developmental process| |animal organ morphogenesis| |embryo development| |regulation of locomotion| |regulation of cellular component movement| |negative regulation of transcription, DNA-templated| |negative regulation of multicellular organismal process| |positive regulation of transcription by RNA polymerase II| |negative regulation of nucleic acid-templated transcription| |negative regulation of RNA biosynthetic process| |negative regulation of RNA metabolic process| |negative regulation of cellular macromolecule biosynthetic process| |negative regulation of nucleobase-containing compound metabolic process| |negative regulation of macromolecule biosynthetic process| |negative regulation of cellular biosynthetic process| |positive regulation of transcription, DNA-templated| |negative regulation of biosynthetic process| |DNA-binding transcription factor activity, RNA polymerase II-specific| |positive regulation of nucleic acid-templated transcription| |positive regulation of RNA biosynthetic process| |regulation of immune system process| |negative regulation of gene expression| |positive regulation of RNA metabolic process| |regulation of cell differentiation| |positive regulation of nucleobase-containing compound metabolic process| |positive regulation of macromolecule biosynthetic process| |positive regulation of cellular biosynthetic process| |positive regulation of gene expression| |positive regulation of biosynthetic process| \\ === CRISPR Data === ^Screen^Score^ |[[:results:exp14|Cycloheximide 0.02μM R00 exp14]]|-1.94| |[[:results:exp176|Apcin 50 to 100μM on day4 R04 exp176]]|2.04| |[[:results:exp93|DABN racemic mixture R03 exp93]]|2.04| |[[:results:exp507|Monensin 0.3μM R08 exp507]]|2.07| |[[:results:exp24|Nocodazole 0.2μM R00 exp24]]|2.08| |[[:results:exp244|SB743921 0.001μM R05 exp244]]|2.28| |[[:results:exp94|Nocodazole 0.1μM R03 exp94]]|2.52| |[[:results:exp33|Rotenone 2μM R00 exp33]]|3.5| No correlation found to any other genes in chemogenomics. Global Fraction of Cell Lines Where Essential: 0/739 ^Tissue^Fraction Of Cell Lines Where Essential^ |1290807.0|0/1| |909776.0|0/1| |bile duct|0/28| |blood|0/28| |bone|0/26| |breast|0/33| |central nervous system|0/56| |cervix|0/4| |colorectal|0/17| |esophagus|0/13| |fibroblast|0/1| |gastric|0/16| |kidney|0/21| |liver|0/20| |lung|0/75| |lymphocyte|0/16| |ovary|0/26| |pancreas|0/24| |peripheral nervous system|0/16| |plasma cell|0/15| |prostate|0/1| |skin|0/24| |soft tissue|0/9| |thyroid|0/2| |upper aerodigestive|0/22| |urinary tract|0/29| |uterus|0/5| == Essentiality in NALM6 == * **Essentiality Rank**: 9856 * **Expression level (log2 read counts)**: -2.84 {{:chemogenomics:nalm6 dist.png?nolink |}}